TSR-033

Modify Date: 2023-01-19 14:01:59

TSR-033 Structure
TSR-033 structure
Common Name TSR-033
CAS Number 2225940-96-3 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of TSR-033


TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity[1].

 Names

Name TSR-033

 TSR-033 Biological Activity

Description TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and PD-1 blocking activity in vitro and in vivo. TSR-033 has anti-tumor activity[1].
Related Catalog
In Vitro TSR-033 (0.01-1000 nmol/L, 48 h) 可以增加原代人类 CD4 T细胞和树突状细胞的 IL2 产生,并增强T细胞效应器功能[1]。
In Vivo TSR-033 (i.p.,10 mg/kg, twice weekly, 40 days) 在 A549 HuNOG-EXL NSCLC 小鼠肿瘤模型中,对肿瘤生长有中等程度的抑制作用,单独治疗终止时TGI 为 23%,而与 TSR-042 联合治疗有累积效应,能更大程度地阻碍肿瘤生长,终止时 TGI 为 45%[1]。
References

[1]. Srimoyee Ghosh, et al. TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo. Mol Cancer Ther. 2019 Mar;18(3):632-641.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties